Herpes Zoster Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Anti-Viral Agents, Anti-Inflammatory Agents, Analgesics, Anticonvulsants Agents, Corticosteroids, Tricyclic Antidepressants, Antihistamines, Others); Vaccine (Zostavax, Shingrix, Others); Route of administration (Oral, Topical, Intravenous, Others); Distribution Channel (Online Pharmacy, Retailers, Others); End Users (Hospitals, Homecare, Specialty Clinics, Others) and Geography

Report Code: TIPRE00023676 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Herpes zoster, also called as shingles is an acute viral infection caused by the varicella-zoster virus, a similar one that causes chickenpox as well. Chickenpox is caused by the initial infection of the VZV virus; after chickenpox is cured, the virus remains inactive in the nerve cells and gets reactive travels to the nerve end, producing blisters. It can cause extreme rashes on the skin along with fever, headache, fatigue, and muscle weakness. The infection can affect anybody with a weak immune system and is primarily prevalent in older adults above the age of 50 years. The disease can be cured by oral medicines, topical and vaccines.

MARKET SCOPE

The "Global Herpes Zoster Drug Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the herpes zoster drug market with detailed market segmentation by drug, vaccine, route of administration, distribution channel, end user, and geography. The report provides key statistics on the market status of the leading herpes zoster drug market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on drug, the global herpes zoster drug market is segmented into anti-viral agents, anti-inflammatory agents, analgesics, anticonvulsants agents, corticosteroids, tricyclic antidepressants, antihistamines and others.
    - Based on vaccine, the market is segmented into zostavax, shingrix and others.
    - Based on route of administration, the market is segmented into oral, topical, intravenous and others.
    - On the basis of distribution channel, the market is bifurcated into online pharmacy, retailers and others.
    - On the basis of end-users, the market is bifurcated into hospitals, homecare, specialty clinics and others.

MARKET DYNAMICS
Drivers:

    - The rising prevalence of herpes zoster, rise in the occurrences of cancer and HIV patients, and increasing elderly population drive the herpes zoster drug market growth.
    - Increasing vaccines and rising healthcare expenditure fuel the market growth.
    - Technological developments and improving healthcare infrastructure propel market growth.

Restraints:

    - High cost of the antibodies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The herpes zoster drug market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the herpes zoster drug market in these regions.

IMPACT OF COVID-19 ON HERPES ZOSTER DRUG MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The increasing prevalence of coronavirus pandemic and rapid rollout of COVID vaccines has led to a decline in sales of shingles vaccine that has impacted the herpes zoster drug market. Due to the prioritization of the public health systems to focus on pandemic vaccination deployment resulted in significant disruption in drug prescriptions. However, with strong underlying demand, the market is expected to witness growth in the future owing to the removal of restrictive measures and new policies by manufacturers.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the herpes zoster drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from herpes zoster drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for herpes zoster drug in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the herpes zoster drug market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Pfizer Inc
    - Abbott
    - Novartis AG
    - Merck & Co., Inc.
    - GlaxoSmithKline plc
    - F. Hoffmann-La Roche Ltd
    - Bristol-Myers Squibb Company
    - Astellas Pharma Inc.
    - GeneOne Life Science
    - Camber Pharmaceuticals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Herpes Zoster Drug Market - By Drug
1.3.2 Herpes Zoster Drug Market - By Vaccine
1.3.3 Herpes Zoster Drug Market - By Route of administration
1.3.4 Herpes Zoster Drug Market - By Distribution Channel
1.3.5 Herpes Zoster Drug Market - By End Users
1.3.6 Herpes Zoster Drug Market - By Region
1.3.6.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HERPES ZOSTER DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. HERPES ZOSTER DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HERPES ZOSTER DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. HERPES ZOSTER DRUG - GLOBAL MARKET OVERVIEW
6.2. HERPES ZOSTER DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. HERPES ZOSTER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. ANTI-VIRAL AGENTS
7.3.1. Overview
7.3.2. Anti-Viral Agents Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY AGENTS
7.4.1. Overview
7.4.2. Anti-Inflammatory Agents Market Forecast and Analysis
7.5. ANALGESICS
7.5.1. Overview
7.5.2. Analgesics Market Forecast and Analysis
7.6. ANTICONVULSANTS AGENTS
7.6.1. Overview
7.6.2. Anticonvulsants Agents Market Forecast and Analysis
7.7. CORTICOSTEROIDS
7.7.1. Overview
7.7.2. Corticosteroids Market Forecast and Analysis
7.8. TRICYCLIC ANTIDEPRESSANTS
7.8.1. Overview
7.8.2. Tricyclic Antidepressants Market Forecast and Analysis
7.9. ANTIHISTAMINES
7.9.1. Overview
7.9.2. Antihistamines Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. HERPES ZOSTER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - VACCINE
8.1. OVERVIEW
8.2. VACCINE MARKET FORECASTS AND ANALYSIS
8.3. ZOSTAVAX
8.3.1. Overview
8.3.2. Zostavax Market Forecast and Analysis
8.4. SHINGRIX
8.4.1. Overview
8.4.2. Shingrix Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. HERPES ZOSTER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. TOPICAL
9.4.1. Overview
9.4.2. Topical Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. HERPES ZOSTER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. ONLINE PHARMACY
10.3.1. Overview
10.3.2. Online Pharmacy Market Forecast and Analysis
10.4. RETAILERS
10.4.1. Overview
10.4.2. Retailers Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. HERPES ZOSTER DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
11.1. OVERVIEW
11.2. END USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. HOMECARE
11.4.1. Overview
11.4.2. Homecare Market Forecast and Analysis
11.5. SPECIALTY CLINICS
11.5.1. Overview
11.5.2. Specialty Clinics Market Forecast and Analysis
11.6. OTHERS
11.6.1. Overview
11.6.2. Others Market Forecast and Analysis

12. HERPES ZOSTER DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Herpes Zoster Drug Market Overview
12.1.2 North America Herpes Zoster Drug Market Forecasts and Analysis
12.1.3 North America Herpes Zoster Drug Market Forecasts and Analysis - By Drug
12.1.4 North America Herpes Zoster Drug Market Forecasts and Analysis - By Vaccine
12.1.5 North America Herpes Zoster Drug Market Forecasts and Analysis - By Route of administration
12.1.6 North America Herpes Zoster Drug Market Forecasts and Analysis - By Distribution Channel
12.1.7 North America Herpes Zoster Drug Market Forecasts and Analysis - By End Users
12.1.8 North America Herpes Zoster Drug Market Forecasts and Analysis - By Countries
12.1.8.1 Canada Herpes Zoster Drug Market
12.1.8.1.1 Canada Herpes Zoster Drug Market by Drug
12.1.8.1.2 Canada Herpes Zoster Drug Market by Vaccine
12.1.8.1.3 Canada Herpes Zoster Drug Market by Route of administration
12.1.8.1.4 Canada Herpes Zoster Drug Market by Distribution Channel
12.1.8.1.5 Canada Herpes Zoster Drug Market by End Users
12.1.8.2 Mexico Herpes Zoster Drug Market
12.1.8.2.1 Mexico Herpes Zoster Drug Market by Drug
12.1.8.2.2 Mexico Herpes Zoster Drug Market by Vaccine
12.1.8.2.3 Mexico Herpes Zoster Drug Market by Route of administration
12.1.8.2.4 Mexico Herpes Zoster Drug Market by Distribution Channel
12.1.8.2.5 Mexico Herpes Zoster Drug Market by End Users
12.1.8.3 US Herpes Zoster Drug Market
12.1.8.3.1 US Herpes Zoster Drug Market by Drug
12.1.8.3.2 US Herpes Zoster Drug Market by Vaccine
12.1.8.3.3 US Herpes Zoster Drug Market by Route of administration
12.1.8.3.4 US Herpes Zoster Drug Market by Distribution Channel
12.1.8.3.5 US Herpes Zoster Drug Market by End Users
12.2. EUROPE
12.2.1 Europe Herpes Zoster Drug Market Overview
12.2.2 Europe Herpes Zoster Drug Market Forecasts and Analysis
12.2.3 Europe Herpes Zoster Drug Market Forecasts and Analysis - By Drug
12.2.4 Europe Herpes Zoster Drug Market Forecasts and Analysis - By Vaccine
12.2.5 Europe Herpes Zoster Drug Market Forecasts and Analysis - By Route of administration
12.2.6 Europe Herpes Zoster Drug Market Forecasts and Analysis - By Distribution Channel
12.2.7 Europe Herpes Zoster Drug Market Forecasts and Analysis - By End Users
12.2.8 Europe Herpes Zoster Drug Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Herpes Zoster Drug Market
12.2.8.1.1 Germany Herpes Zoster Drug Market by Drug
12.2.8.1.2 Germany Herpes Zoster Drug Market by Vaccine
12.2.8.1.3 Germany Herpes Zoster Drug Market by Route of administration
12.2.8.1.4 Germany Herpes Zoster Drug Market by Distribution Channel
12.2.8.1.5 Germany Herpes Zoster Drug Market by End Users
12.2.8.2 France Herpes Zoster Drug Market
12.2.8.2.1 France Herpes Zoster Drug Market by Drug
12.2.8.2.2 France Herpes Zoster Drug Market by Vaccine
12.2.8.2.3 France Herpes Zoster Drug Market by Route of administration
12.2.8.2.4 France Herpes Zoster Drug Market by Distribution Channel
12.2.8.2.5 France Herpes Zoster Drug Market by End Users
12.2.8.3 Italy Herpes Zoster Drug Market
12.2.8.3.1 Italy Herpes Zoster Drug Market by Drug
12.2.8.3.2 Italy Herpes Zoster Drug Market by Vaccine
12.2.8.3.3 Italy Herpes Zoster Drug Market by Route of administration
12.2.8.3.4 Italy Herpes Zoster Drug Market by Distribution Channel
12.2.8.3.5 Italy Herpes Zoster Drug Market by End Users
12.2.8.4 Spain Herpes Zoster Drug Market
12.2.8.4.1 Spain Herpes Zoster Drug Market by Drug
12.2.8.4.2 Spain Herpes Zoster Drug Market by Vaccine
12.2.8.4.3 Spain Herpes Zoster Drug Market by Route of administration
12.2.8.4.4 Spain Herpes Zoster Drug Market by Distribution Channel
12.2.8.4.5 Spain Herpes Zoster Drug Market by End Users
12.2.8.5 United Kingdom Herpes Zoster Drug Market
12.2.8.5.1 United Kingdom Herpes Zoster Drug Market by Drug
12.2.8.5.2 United Kingdom Herpes Zoster Drug Market by Vaccine
12.2.8.5.3 United Kingdom Herpes Zoster Drug Market by Route of administration
12.2.8.5.4 United Kingdom Herpes Zoster Drug Market by Distribution Channel
12.2.8.5.5 United Kingdom Herpes Zoster Drug Market by End Users
12.2.8.6 Rest of Europe Herpes Zoster Drug Market
12.2.8.6.1 Rest of Europe Herpes Zoster Drug Market by Drug
12.2.8.6.2 Rest of Europe Herpes Zoster Drug Market by Vaccine
12.2.8.6.3 Rest of Europe Herpes Zoster Drug Market by Route of administration
12.2.8.6.4 Rest of Europe Herpes Zoster Drug Market by Distribution Channel
12.2.8.6.5 Rest of Europe Herpes Zoster Drug Market by End Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Herpes Zoster Drug Market Overview
12.3.2 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis
12.3.3 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By Drug
12.3.4 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By Vaccine
12.3.5 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By Route of administration
12.3.6 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By Distribution Channel
12.3.7 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By End Users
12.3.8 Asia-Pacific Herpes Zoster Drug Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Herpes Zoster Drug Market
12.3.8.1.1 Australia Herpes Zoster Drug Market by Drug
12.3.8.1.2 Australia Herpes Zoster Drug Market by Vaccine
12.3.8.1.3 Australia Herpes Zoster Drug Market by Route of administration
12.3.8.1.4 Australia Herpes Zoster Drug Market by Distribution Channel
12.3.8.1.5 Australia Herpes Zoster Drug Market by End Users
12.3.8.2 China Herpes Zoster Drug Market
12.3.8.2.1 China Herpes Zoster Drug Market by Drug
12.3.8.2.2 China Herpes Zoster Drug Market by Vaccine
12.3.8.2.3 China Herpes Zoster Drug Market by Route of administration
12.3.8.2.4 China Herpes Zoster Drug Market by Distribution Channel
12.3.8.2.5 China Herpes Zoster Drug Market by End Users
12.3.8.3 India Herpes Zoster Drug Market
12.3.8.3.1 India Herpes Zoster Drug Market by Drug
12.3.8.3.2 India Herpes Zoster Drug Market by Vaccine
12.3.8.3.3 India Herpes Zoster Drug Market by Route of administration
12.3.8.3.4 India Herpes Zoster Drug Market by Distribution Channel
12.3.8.3.5 India Herpes Zoster Drug Market by End Users
12.3.8.4 Japan Herpes Zoster Drug Market
12.3.8.4.1 Japan Herpes Zoster Drug Market by Drug
12.3.8.4.2 Japan Herpes Zoster Drug Market by Vaccine
12.3.8.4.3 Japan Herpes Zoster Drug Market by Route of administration
12.3.8.4.4 Japan Herpes Zoster Drug Market by Distribution Channel
12.3.8.4.5 Japan Herpes Zoster Drug Market by End Users
12.3.8.5 South Korea Herpes Zoster Drug Market
12.3.8.5.1 South Korea Herpes Zoster Drug Market by Drug
12.3.8.5.2 South Korea Herpes Zoster Drug Market by Vaccine
12.3.8.5.3 South Korea Herpes Zoster Drug Market by Route of administration
12.3.8.5.4 South Korea Herpes Zoster Drug Market by Distribution Channel
12.3.8.5.5 South Korea Herpes Zoster Drug Market by End Users
12.3.8.6 Rest of Asia-Pacific Herpes Zoster Drug Market
12.3.8.6.1 Rest of Asia-Pacific Herpes Zoster Drug Market by Drug
12.3.8.6.2 Rest of Asia-Pacific Herpes Zoster Drug Market by Vaccine
12.3.8.6.3 Rest of Asia-Pacific Herpes Zoster Drug Market by Route of administration
12.3.8.6.4 Rest of Asia-Pacific Herpes Zoster Drug Market by Distribution Channel
12.3.8.6.5 Rest of Asia-Pacific Herpes Zoster Drug Market by End Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Herpes Zoster Drug Market Overview
12.4.2 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis
12.4.3 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By Drug
12.4.4 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By Vaccine
12.4.5 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By Route of administration
12.4.6 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By Distribution Channel
12.4.7 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By End Users
12.4.8 Middle East and Africa Herpes Zoster Drug Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Herpes Zoster Drug Market
12.4.8.1.1 South Africa Herpes Zoster Drug Market by Drug
12.4.8.1.2 South Africa Herpes Zoster Drug Market by Vaccine
12.4.8.1.3 South Africa Herpes Zoster Drug Market by Route of administration
12.4.8.1.4 South Africa Herpes Zoster Drug Market by Distribution Channel
12.4.8.1.5 South Africa Herpes Zoster Drug Market by End Users
12.4.8.2 Saudi Arabia Herpes Zoster Drug Market
12.4.8.2.1 Saudi Arabia Herpes Zoster Drug Market by Drug
12.4.8.2.2 Saudi Arabia Herpes Zoster Drug Market by Vaccine
12.4.8.2.3 Saudi Arabia Herpes Zoster Drug Market by Route of administration
12.4.8.2.4 Saudi Arabia Herpes Zoster Drug Market by Distribution Channel
12.4.8.2.5 Saudi Arabia Herpes Zoster Drug Market by End Users
12.4.8.3 U.A.E Herpes Zoster Drug Market
12.4.8.3.1 U.A.E Herpes Zoster Drug Market by Drug
12.4.8.3.2 U.A.E Herpes Zoster Drug Market by Vaccine
12.4.8.3.3 U.A.E Herpes Zoster Drug Market by Route of administration
12.4.8.3.4 U.A.E Herpes Zoster Drug Market by Distribution Channel
12.4.8.3.5 U.A.E Herpes Zoster Drug Market by End Users
12.4.8.4 Rest of Middle East and Africa Herpes Zoster Drug Market
12.4.8.4.1 Rest of Middle East and Africa Herpes Zoster Drug Market by Drug
12.4.8.4.2 Rest of Middle East and Africa Herpes Zoster Drug Market by Vaccine
12.4.8.4.3 Rest of Middle East and Africa Herpes Zoster Drug Market by Route of administration
12.4.8.4.4 Rest of Middle East and Africa Herpes Zoster Drug Market by Distribution Channel
12.4.8.4.5 Rest of Middle East and Africa Herpes Zoster Drug Market by End Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Herpes Zoster Drug Market Overview
12.5.2 South and Central America Herpes Zoster Drug Market Forecasts and Analysis
12.5.3 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By Drug
12.5.4 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By Vaccine
12.5.5 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By Route of administration
12.5.6 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By Distribution Channel
12.5.7 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By End Users
12.5.8 South and Central America Herpes Zoster Drug Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Herpes Zoster Drug Market
12.5.8.1.1 Brazil Herpes Zoster Drug Market by Drug
12.5.8.1.2 Brazil Herpes Zoster Drug Market by Vaccine
12.5.8.1.3 Brazil Herpes Zoster Drug Market by Route of administration
12.5.8.1.4 Brazil Herpes Zoster Drug Market by Distribution Channel
12.5.8.1.5 Brazil Herpes Zoster Drug Market by End Users
12.5.8.2 Argentina Herpes Zoster Drug Market
12.5.8.2.1 Argentina Herpes Zoster Drug Market by Drug
12.5.8.2.2 Argentina Herpes Zoster Drug Market by Vaccine
12.5.8.2.3 Argentina Herpes Zoster Drug Market by Route of administration
12.5.8.2.4 Argentina Herpes Zoster Drug Market by Distribution Channel
12.5.8.2.5 Argentina Herpes Zoster Drug Market by End Users
12.5.8.3 Rest of South and Central America Herpes Zoster Drug Market
12.5.8.3.1 Rest of South and Central America Herpes Zoster Drug Market by Drug
12.5.8.3.2 Rest of South and Central America Herpes Zoster Drug Market by Vaccine
12.5.8.3.3 Rest of South and Central America Herpes Zoster Drug Market by Route of administration
12.5.8.3.4 Rest of South and Central America Herpes Zoster Drug Market by Distribution Channel
12.5.8.3.5 Rest of South and Central America Herpes Zoster Drug Market by End Users

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. HERPES ZOSTER DRUG MARKET, KEY COMPANY PROFILES
14.1. PFIZER INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. NOVARTIS AG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. MERCK AND CO., INC.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. GLAXOSMITHKLINE PLC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. F. HOFFMANN-LA ROCHE LTD
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BRISTOL-MYERS SQUIBB COMPANY
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ASTELLAS PHARMA INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. GENEONE LIFE SCIENCE
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. CAMBER PHARMACEUTICALS
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

- Pfizer Inc
- Abbott
- Novartis AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Astellas Pharma Inc.
- GeneOne Life Science
- Camber Pharmaceuticals
TIPRE00023676
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking